Background: Longitudinal studies on healthy participants have shown that subjective memory impairment (defined as subjective cognitive complaints with normal cognitive objective performance) might be a strong predictor of mild cognitive impairment (MCI). Parkinson disease (PD) also manifests cognitive disturbances, but whether subjective memory complaints may predict the development of MCI in PD has not yet been explored.Methods:We prospectively screened newly diagnosed, untreated patients with PD in order to evaluate whether subjective memory complaints may predict development of MCI over a 2-year follow-up evaluation. Results: We enrolled 76 de novo untreated patients with PD. Of the 76 patients, 23 (30.3%) complained memory issues. Among...
Objective: There is growing interest in investigating prospective memory (PM) functioning in individ...
Background: Subjective cognitive decline (SCD) may occur very early in the course of Parkinson's dis...
BackgroundCognitive decline creates substantial morbidity and cost in Parkinson's disease (PD) and c...
Background: Longitudinal studies on healthy participants have shown that subjective memory impairmen...
Background: Longitudinal studies on healthy participants have shown that subjective memory impairmen...
Subjective memory complaints (SMC) may represent the preclinical phase of Mild Cognitive Impairment ...
BackgroundThe presence of subjective cognitive complaints (SCC) as a predictor of cognitive impairme...
OBJECTIVE: To describe the frequency of mild cognitive impairment (MCI) in Parkinson disease (PD) in...
INTRODUCTION: In PD, Mild Cognitive Impairment (PD-MCI) occurs since early stages of disease. The ai...
INTRODUCTION In PD, Mild Cognitive Impairment (PD-MCI) occurs since early stages of disease. The a...
Aim: The aim of this study was to identify mild cognitive deficits in Parkinson's disease (PD) prior...
Ample evidence has suggested that individuals with subjective memory complaints are at a higher risk...
INTRODUCTION: In PD, Mild Cognitive Impairment (PD-MCI) occurs since early stages of disease. The a...
Increasing evidence suggests that subjective cognitive decline (SCD) is a potential predictor of fut...
Approximately 30% of Parkinson's disease (PD) patients show impaired cognitive performance, which is...
Objective: There is growing interest in investigating prospective memory (PM) functioning in individ...
Background: Subjective cognitive decline (SCD) may occur very early in the course of Parkinson's dis...
BackgroundCognitive decline creates substantial morbidity and cost in Parkinson's disease (PD) and c...
Background: Longitudinal studies on healthy participants have shown that subjective memory impairmen...
Background: Longitudinal studies on healthy participants have shown that subjective memory impairmen...
Subjective memory complaints (SMC) may represent the preclinical phase of Mild Cognitive Impairment ...
BackgroundThe presence of subjective cognitive complaints (SCC) as a predictor of cognitive impairme...
OBJECTIVE: To describe the frequency of mild cognitive impairment (MCI) in Parkinson disease (PD) in...
INTRODUCTION: In PD, Mild Cognitive Impairment (PD-MCI) occurs since early stages of disease. The ai...
INTRODUCTION In PD, Mild Cognitive Impairment (PD-MCI) occurs since early stages of disease. The a...
Aim: The aim of this study was to identify mild cognitive deficits in Parkinson's disease (PD) prior...
Ample evidence has suggested that individuals with subjective memory complaints are at a higher risk...
INTRODUCTION: In PD, Mild Cognitive Impairment (PD-MCI) occurs since early stages of disease. The a...
Increasing evidence suggests that subjective cognitive decline (SCD) is a potential predictor of fut...
Approximately 30% of Parkinson's disease (PD) patients show impaired cognitive performance, which is...
Objective: There is growing interest in investigating prospective memory (PM) functioning in individ...
Background: Subjective cognitive decline (SCD) may occur very early in the course of Parkinson's dis...
BackgroundCognitive decline creates substantial morbidity and cost in Parkinson's disease (PD) and c...